RE: Plcebo Corrected PK/PD

From: Atul Bhattaram Venkatesh Date: March 04, 2005 technical Source: cognigencorp.com
From: "Bhattaram, Atul" BhattaramA@cder.fda.gov Subject: RE: [NMusers] Plcebo Corrected PK/PD Date: Fri, March 4, 2005 4:05 pm Hello Nick I dont think you can estimate the "true variability" unless one does a cross-over design. If you dont have placebo data in the same subject for symptomatic drugs (anti-hypertensives) how would you estimate the "true variability"?. Venkatesh Atul Bhattaram Pharmacometrics, FDA
Mar 02, 2005 Manoj Khurana Plcebo Corrected PK/PD
Mar 02, 2005 William Bachman RE: Plcebo Corrected PK/PD
Mar 02, 2005 Jogarao V Gobburu RE: Plcebo Corrected PK/PD
Mar 04, 2005 Nick Holford RE: Plcebo Corrected PK/PD
Mar 04, 2005 Jogarao V Gobburu RE: Plcebo Corrected PK/PD
Mar 04, 2005 Nick Holford Re: Plcebo Corrected PK/PD
Mar 04, 2005 Mats Karlsson Re: Plcebo Corrected PK/PD
Mar 04, 2005 Atul Bhattaram Venkatesh RE: Plcebo Corrected PK/PD
Mar 04, 2005 William Bachman RE: Plcebo Corrected PK/PD
Mar 04, 2005 Nick Holford Re: Plcebo Corrected PK/PD
Mar 04, 2005 Nick Holford Re: Plcebo Corrected PK/PD
Mar 04, 2005 Jogarao V Gobburu RE: Plcebo Corrected PK/PD
Mar 04, 2005 Mats Karlsson Re: Plcebo Corrected PK/PD
Mar 05, 2005 Nick Holford Re: Plcebo Corrected PK/PD
Mar 07, 2005 William Bachman RE: Placebo Corrected PK/PD